News | Artificial Intelligence | February 01, 2021

Canon Medical’s AI-Based Image Reconstruction Technology Now Available for Wider Range

Advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR) technology expands to wider range of clinical applications for the Vantage Orian 1.5T MR system

Advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR) technology expands to wider range of clinical applications for the Vantage Orian 1.5T MR system

February 1, 2021 — Canon Medical is bringing the power of accessible artificial intelligence (AI) for improved image quality to more patients with expanded clinical indications for 1.5T MR. Advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR) can now be used for 96 percent of all procedures using the Vantage Orian 1.5T MR system, expanding from previously FDA-cleared brain and knee indications to a vastly larger number of clinical indications, from prostate to shoulders, including all joints, cardiac, pelvis, abdomen and spine.

AiCE was trained using vast amounts of high-quality image data, and features a deep learning neural network that can reduce noise and boost signal to quickly deliver sharp, clear and distinct images, allowing clinicians to boost image quality, performance, productivity and throughput on a whole new scale.

“As we continue to expand the availability of AiCE, Canon Medical is ensuring that the maximum number of patients can benefit from the advanced images, expanded clinical capabilities and seamless integration that this advanced AI technology provides,” said Jonathan Furuyama, managing director, MR Business Unit, Canon Medical Systems USA, Inc. “In today’s environment, making images easy to read and acquire is more important than ever, and this is the latest demonstration of our commitment to offering accessible AI that clinicians can use to make the greatest impact on patient care.”

For more information: www.us.medical.canon

Related Content

Guerbet announced the launch of OptiProtect 3S, a new range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.
News | Contrast Media Injectors | February 25, 2021
February 25, 2021 — Guerbet announced the launch of ...
Advanced technologies and applications such as point-of-care, pediatrics, dry-magnets, compact MRI and fusion imaging are driving global market
News | Magnetic Resonance Imaging (MRI) | February 24, 2021
February 24, 2021 — Frost & Sullivan's recent analysis, Technological Advancements and Emerging Applications in t
55-year-old woman who underwent screening mammogram and ultrasound 7 days after first COVID-19 vaccination dose. Screening mammogram and US demonstrated unilateral left axillary lymph node with cortical thickness of 5 mm on ultrasound (not shown). BI-RADS category 0 was assigned. Ultrasound from diagnostic work-up performed 7 days later showed no change in lymph node size. BI-RADS 3 was assigned. #COVIDvaccine #COVID19

55-year-old woman who underwent screening mammogram and ultrasound 7 days after first COVID-19 vaccination dose. Screening mammogram and US demonstrated unilateral left axillary lymph node with cortical thickness of 5 mm on ultrasound (not shown). BI-RADS category 0 was assigned. Ultrasound from diagnostic work-up performed 7 days later showed no change in lymph node size. BI-RADS 3 was assigned.

News | Breast Imaging | February 24, 2021
Detroit-based magnetic resonance imaging (MRI) technology company SpinTech, Inc. has acquired medical-imaging research and technology developer Magnetic Resonance Innovations, Inc. (MR Innovations).
News | Magnetic Resonance Imaging (MRI) | February 24, 2021
February 24, 2021 — Detroit-based magnetic resonance...
Findings indicate that PPC and GG are highly predictive of overall upstaging by PSMA PET/CT for patients with high-risk prostate cancer

Image courtesy of UCLA Health

News | PET-CT | February 23, 2021
February 23, 2021 — A...
icobrain cva allows the quantitative assessment of tissue perfusion by reporting the volume of core and perfusion lesion by quantifying Tmax abnormality and CBF abnormality together with the mismatch volume and ratio
News | Artificial Intelligence | February 23, 2021
February 23, 2021 — icometrix, world leader in imaging...
Dr Sahar Saleem placing the mummy in the CT scanner

Dr. Sahar Saleem placing the mummy in the CT scanner. Image courtesy of Sahar Saleem

News | Computed Tomography (CT) | February 22, 2021
February 22, 2021 — Modern medical technology is helping scholars tell a more nuanced story about the fate of an anci